Event
‘New technologies and modalities bring new challenges and opportunities in drug discovery’
Monday 17 June 2024
The Bridget Ogilvie Lecture 2024 by Dr Fiona Marshall, President of Biomedical Research, Novartis, MA, USA
University of Dundee
Dow Street
Dundee DD1 5HL
Host: Professor David Horn
Venue: MSI Large Lecture Theatre, SLS
Followed by reception in CTIR ‘street’
About the lecture series:
The Bridget Ogilvie Lecture is named after Dame Bridget Ogilvie who was Director of the Wellcome Trust 1991 - 1998 and who played an important role in the development of the College of Life Sciences, in particular in the special award of £10 million that lead to the building of the Wellcome Trust Building in 1997. Each Wellcome funded Division in SLS takes turns in nominating the Bridget Ogilvie Lecturer and this year is the turn of BCDD.
Biography:
Fiona Marshall FRS FMedSci is President of Biomedical Research at Novartis, the company’s innovation engine, where she leads approximately 5,300 scientists and other associates across six research sites dedicated to the discovery of high-value medicines for patients. She is a British pharmacologist, founder and Senior Vice President of Discovery, Preclinical & Translational Medicine at Merck & Co. She previously served as Chief Scientific Officer at Heptares Therapeutic, where she was Vice President of the Japanese biopharmaceutical company Sosei. She was elected Fellow of the Academy of Medical Sciences in 2016 and the Royal Society in 2021.